Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 09, 2026 07:05 ET | Source: uniQure Inc.

uniQure Announces Type A Meeting Scheduled with FDA

LEXINGTON, Mass. and AMSTERDAM, Jan. 09, 2026 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical...
January 09, 2026 07:05 ET | Source: La Rosa Holdings Corp.

La Rosa Holdings Corp. Announces Closing of Initial Funding Under $250 Million Note Facility as Part of $1.25 Billion AI Infrastructure Program

Celebration, FL, Jan. 09, 2026 (GLOBE NEWSWIRE) -- La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a real estate and PropTech enterprise, today announced an initial closing of an...
January 09, 2026 07:05 ET | Source: Ping An Biomedical Co., Ltd.

Ping An Biomedical Co., Ltd. Receives Strategic Investment from Leading Industry Capital, Accelerating Growth in Biopharmaceutical Innovation

Ping An Biomedical (NASDAQ: PASW) secured investments from 58.com’s Yao Jinbo, Amiba Capital’s Wang Donghui, and Magcloud’s Li Daxue.
January 09, 2026 07:02 ET | Source: Ocugen

Ocugen CEO to Present at J.P. Morgan 2026 Healthcare Conference

MALVERN, Pa., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that...
January 09, 2026 07:00 ET | Source: Athira Pharma, Inc.

Athira Pharma Announces Name Change to LeonaBio, Inc. with New Ticker “LONA”

Athira Pharma, Inc. today announced that it has changed its name to LeonaBio, Inc.
January 09, 2026 07:00 ET | Source: Tiziana Life Sciences Ltd.

Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco

BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3...
January 09, 2026 07:00 ET | Source: Capital City Bank Group

Capital City Bank Group, Inc. to Announce Quarterly Earnings Results on Tuesday, January 27, 2026

TALLAHASSEE, Fla., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Capital City Bank Group, Inc. (NASDAQ: CCBG) announced today that it will release fourth quarter and year-end 2025 results on Tuesday, January...
January 09, 2026 07:00 ET | Source: Immunocore Holdings plc

Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference

Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference Reaching more metastatic uveal melanoma patients with KIMMTRAK (tebentafusp) in 2026 through US...
January 09, 2026 07:00 ET | Source: Aquestive Therapeutics, Inc.

Aquestive Therapeutics Announces Regulatory Development for Anaphylm™ (dibutepinephrine) Sublingual Film and Provides Business Update

Announces receipt of FDA letter stating it has identified deficiencies that preclude labeling discussions for Anaphylm at this time Receives confirmation from FDA that Agency’s review of Anaphylm NDA...
January 09, 2026 07:00 ET | Source: MapLight Therapeutics, Inc.

MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026

SAN FRANCISCO and BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (MapLight) (Nasdaq: MPLT) today announced an update to the expected timing of topline results for its ongoing...